IPO Boutique

Auspex Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Auspex Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Auspex PharmaceuticalsASPX -
NASDAQ
$10.00-$12.00 $12.00 $15.007 million2/5/2014
Stifel, BMO Capital Markets
Co-Manager(s):
Baird, William Blair, Ladenburg Thalmann
Health Care
Filing(s):

Filed 2013-12-20



Auspex Pharmaceuticals Quote & Chart - Click for current quote - ASPX

About Auspex Pharmaceuticals (adapted from Auspex Pharmaceuticals prospectus):
They are a biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases, which are rare diseases that affect fewer than 200,000 people in the United States and that may often present unmet medical needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ASPX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved